You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Biochemically recurrent prostate cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

Not yet recruiting
  • Prostate Cancer
  • Biochemically Recurrent
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Biochemical Recurrent Prostate Cancer Trial run by the National Cancer Institute (NCI) (Radium-223, 18F Sodium Fluoride)

Recruiting
  • Biochemical Recurrent Prostate Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Prostate Cancer Trial run by the National Cancer Institute (NCI) (PROSTVAC-V, PROSTVAC-F, MSB0011359C (M7824))

Recruiting
  • Prostate Cancer
  • PROSTVAC-V
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Prostate Cancer Trial in Boston, South Weymouth, Londonderry (Nivolumab)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +4 more
Dec 5, 2022

Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Houston (Fluorine F

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +2 more
  • Fluorine F 18 rhPSMA-7.3
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)

Suspended
  • Biochemically Recurrent Prostate Carcinoma
  • Gallium Ga 68-labeled PSMA-11
  • Positron Emission Tomography
  • Duarte, California
    City of Hope Medical Center
Oct 12, 2022

Prostate Cancer Trial in Darlinghurst (SUBA-itraconazole, Hydroxychloroquine)

Recruiting
  • Prostate Cancer
  • Darlinghurst, New South Wales, Australia
    St Vincent's Hospital
May 3, 2022

Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Durvalumab
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

Prostate Trial in United States (Olaparib)

Recruiting
  • Prostate
  • Baltimore, Maryland
  • +3 more
Feb 14, 2022

Prostate Cancer Trial in Duarte, South Pasadena (white button mushroom extract, flow cytometry, immunologic technique)

Completed
  • Prostate Cancer
  • white button mushroom extract
  • +5 more
  • Duarte, California
  • +1 more
Mar 16, 2022

Prostate Cancer Trial in Irvine (DCFPyL PET/CT)

Recruiting
  • Prostate Cancer
  • DCFPyL PET/CT
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
Jul 26, 2021

Prostate Cancer Trial in Pittsburgh (18F-DCFPyL)

Active, not recruiting
  • Prostate Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 8, 2022

Prostate Adenocarcinoma Trial in Palo Alto (Gallium Ga 68-labeled GRPR Antagonist BAY86-7548, Magnetic Resonance Imaging,

Active, not recruiting
  • Prostate Adenocarcinoma
  • Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
May 3, 2022

Prostate Cancer Trial in Edmonton (18F-PSMA-1007)

Active, not recruiting
  • Prostate Cancer
  • 18F-PSMA-1007
  • Edmonton, Alberta, Canada
    University of Alberta
Aug 10, 2022

Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)

Not yet recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Biospecimen Collection
  • +6 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Oct 25, 2023

Prostate Cancer Recurrent, Prostate Cancer, Prostate Adenocarcinoma Trial in Lexington (Epidiolex Oral Liquid Product)

Completed
  • Prostate Cancer Recurrent
  • +2 more
  • Epidiolex Oral Liquid Product
  • Lexington, Kentucky
    Markey Cancer Center
Oct 7, 2021

Recurrent Prostate Cancer After Surgery Trial in Rochester (Daily-adaptive Stereotactic Body Radiation Therapy)

Not yet recruiting
  • Recurrent Prostate Cancer After Surgery
  • Daily-adaptive Stereotactic Body Radiation Therapy
  • Rochester, New York
    Wilmot Cancer Institute - Dept of Radiation Oncology
Jul 7, 2023

Recurrent Prostate Cancer Trial in New York (ADXS-504)

Recruiting
  • Recurrent Prostate Cancer
  • New York, New York
    Columbia University Irving Medical Center
Oct 10, 2021

Metastatic Castration Sensitive Prostate Cancer Trial in New York (Degarelix, Ipilimumab, Radical Prostatectomy)

Active, not recruiting
  • Metastatic Castration Sensitive Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 4, 2022

Prostate Cancer Trial in St Leonards, Perth (177Lu-DOTA-TLX591)

Not yet recruiting
  • Prostate Cancer
  • 177Lu-DOTA-TLX591
  • St Leonards, New South Wales, Australia
  • +1 more
Jul 18, 2022

Metastatic Prostate Cancer, Stage IIB Prostate Cancer, Stage IIC Prostate Cancer Trial in Philadelphia (Interview, Internet

Active, not recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +4 more
  • Interview
  • +5 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Oct 25, 2022

Circulating Tumor Cells in High Risk and Early Metastatic

Recruiting
  • High Risk Prostate Carcinoma
  • +3 more
  • Blood collection
  • Bala-Cynwyd, Pennsylvania
  • +1 more
Jun 28, 2022

Prostate Cancer Trial in United States (Olaparib, Durvalumab)

Active, not recruiting
  • Prostate Cancer
  • Duarte, California
  • +7 more
Mar 30, 2022

Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +10 more
  • Radiation therapy
  • +2 more
  • Atlanta, Georgia
  • +3 more
Jun 7, 2022

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Oligometastatic Prostate Carcinoma Trial in Houston

Withdrawn
  • Biochemically Recurrent Prostate Carcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 14, 2021